Acute myelomonocytic leukemia, in remission

This code signifies a current diagnosis of acute myelomonocytic leukemia (AMML), a type of acute myeloid leukemia (AML) characterized by the proliferation of both myeloid and monocytic blast cells, that is currently in a state of remission. Remission indicates that the signs and symptoms of the leukemia have significantly decreased or disappeared, often due to successful treatment.

Use this code when the patient has a documented history of acute myelomonocytic leukemia and current medical records confirm that the disease is in remission. This typically applies to patients undergoing follow-up care after induction or consolidation chemotherapy, or those in a maintenance phase. Documentation should clearly state "acute myelomonocytic leukemia in remission" or similar phrasing.

• Do not use this code if the patient is still actively receiving treatment for active disease; instead, use the code for active AMML.
• Ensure documentation explicitly states "in remission" to support the use of this code.
• Consider sequencing this code as a secondary diagnosis if a complication or other condition is the primary reason for the encounter.